In this study we have investigated the eects of low dose ionizing radiation (2 Gy) on p70 S6 kinase and Akt signaling with respect to Erb-B receptors in both the A431 squamous and the MDA-MB-231 mammary carcinoma cell lines. Ionizing radiation caused a 2 ± 3-fold increase in p70 S6 kinase activity that was blocked pharmacologically using an EGFR inhibitor (AG1478) alone, or in combination with an Erb-B2 inhibitor (AG825). These results suggested that both EGFR and Erb-B2 receptors could initiate radiation-induced activation of p70 S6K. EGFR dependent Erb-B3 signaling also contributed to p70 S6 kinase activity through recruitment and activation of PI3K, which has been shown to regulate p70 S6 kinase activity. Furthermore, inhibition of the EGFR blocked IR stimulated increases in protein translation, a biologic consequence of p70 S6 kinase activation. We also report that ionizing radiation stimulated Akt activity that was partially independent of PI3K activity, but dependent on Erb-B2 function. Erb-B2 inhibition also correlated with enhanced apoptosis following IR exposure, suggesting an important role for Erb-B2 in cell survival. Together this work demonstrates that the Erb-B receptor tyrosine kinase network stimulates cytoprotective p70 S6 kinase and Akt activity in response to clinically relevant doses of ionizing radiation.
Introduction
Previous investigations by our laboratory have de®ned the epidermal growth factor receptor (EGFR/Erb-B1) family of receptor tyrosine kinases (RTKs), including Erb-B2, Erb-B3, and Erb-B4, as key signaling molecules that are activated by ionizing radiation (IR) (Schmidt-Ullrich et al., 1997; Bowers et al., 2001) . Further investigations of the signaling cascades initiated by these receptors have identi®ed the mitogenactivated protein kinases (MAPKs) as EGFR-dependent, downstream signaling intermediates that participate in protecting the cell from the toxic eects of IR. These responses have been identi®ed in a spectrum of human cell lines tested, including breast carcinoma cell lines (Schmidt-Ullrich et al., 1996; Contessa et al., 1999; Bowers et al., 2001) , a squamous carcinoma cell line (Schmidt-Ullrich et al., 1997), glioma cell lines (Lammering et al., 2001b) , and a prostate carcinoma cell line (Hagan et al., 2000) .
Based upon these ®ndings, we studied the eects of EGFR inhibition on radiosensitivity. Initially we demonstrated that the inducible expression of a dominant negative EGFR (EGFR-CD533) decreased the proliferative capacity of MDA-MB-231 cells following multiple doses of IR. This work identi®ed EGFR inhibition as a potential therapeutic maneuver to enhance the eects of IR Reardon et al., 1999) . Further use of EGFR-CD533 in an adenoviral (Ad) delivery system illustrated that blocking EGFR function radiosensitizes several dierent types of carcinoma cells lines following single doses of IR (Lammering et al., 2001b) . More recently we have shown that infusion of Ad-EGFR-CD533 radiosensitizes MDA-MB-231 xenograft tumors in nude mice (Lammering et al., 2001a) . These studies have provided a biological basis for understanding the combined eects of EGFR inhibition and radiation therapy on tumor cell proliferation , 2000 .
The results of these experiments warrant further studies investigating the mechanisms of Erb-B-dependent signal transduction in response to IR. In this study we focus on the phosphatidylinositol-3-kinase (PI3K) signal transduction cascade, another pathway proposed to be involved in the regulation of cellular mitogenesis and survival (Kapeller and Cantley, 1994; Rameh and Cantley, 1999) . Class I PI3Ks are activated by growth factors that are ligands for Erb-B RTKs. One member of this family, Erb-B3, contains two phosphorylation sites within consensus sequences for PI3K binding. Phosphorylation of these motifs recruits and activates the p85 regulatory subunit of PI3K by SH2 interactions (Hellyer et al., 1998) . Because Erb-B3 lacks an active kinase domain, it relies upon heterodimerization with other Erb-B family receptors or tyrosine kinases for this phosphorylation. In contrast, the EGFR, which contains a functional kinase domain, does not contain PI3K binding sequences and activates PI3K by heterodimerization with other Erb-B molecules (Kim et al., 1994; Solto et al., 1994) .
Downstream of PI3K are two eector molecules, the p70 S6K and the proto-oncogene Akt. The p70 S6K, a gene whose over-expression is a negative prognostic indicator for breast cancer (Barlund et al., 2000) , has been shown to regulate both protein synthesis (Jeeries et al., 1997) and the cell cycle (Lane et al., 1993) , while Akt has been implicated in the regulation of apoptosis (Kennedy et al., 1999) . Previous reports have indicated that the PI3K pathway has a role in cellular radiation responses. Carter et al. (1998) demonstrated IRinduced activation of the P70 S6K in A431 carcinoma cells, while Wick et al. (1999) have shown that expression of PTEN, the phosphatase that counteracts the eects of PI3K, radiosensitizes glioma cells lacking a functional copy of this gene. These studies have provided clues about the role of IR in activating the PI3K signal transduction cascade, and suggest that regulating PI3K signaling could also alter cellular responses to IR. Therefore, the present study examines the role of Erb-B receptors in mediating the IRinduced activation of the PI3K/p70 S6K and Akt signal transduction cascades in both the A431 squamous carcinoma and MDA-MB-231 breast carcinoma cell lines.
Results

Activation of the p70 S6K by IR is dependent on PI3K and EGFR function
Immune complex kinase assays were performed to determine the eect of IR on the p70 S6K (Figure 1 ). IR generates similar activation pro®les for p70 S6K in both A431 and MDA-MB-231 carcinoma cell lines. Following IR treatment, p70 S6K activity increases within minutes, achieves a maximal activation of 15 min, and persists for up to 45 min. A dose of 2 Gy results in a 2.6+0.3-fold activation in A431 cells and a 2.1+0.2-fold activation in MDA-MB-231 cells (Figure 1a,b) . Pretreatment of cells with LY294002, a PI3K inhibitor, reduces the basal activity of p70 S6K in A431 and MDA-M-231 cells to 28+10% and 34+5%, respectively, of control values and abolishes IR-induced activation of p70 S6K.
EGFR inhibition with the tyrphostin, AG1478, also inhibits p70 S6K activity. For these and the later series of experiments we used the AG1478 and AG825 inhibitors at concentrations determined to be speci®c for either EGFR or Erb-B2 (Bowers et al., 2001) . In A431 cells, pretreatment with AG1478 inhibits basal activity of p70 S6K by 58+7% of controls and completely blocks all IR-induced activation of p70 S6K (Figure 1a) . These results indicate that EGFR function is necessary for IR-induced p70S6K activity in A431 cells. Similar results were obtained with MDA-MB-231 cells, where EGFR inhibition partially blocks IR-induced activation of p70 S6K, but does not Figure 1 Activation pro®les and sensitivity of p70 S6K to EGFR and PI3K inhibition. (a) p70 S6 Kinase activation time courses for A431 and (b) MDA-MB-231 cells in response to IR (2 Gy). The cells were pretreated with either 5 mM AG1478 for 1 h or 50 mM LY294002 for 1.5 h. p70 S6 Kinase was immunoprecipitated as described in Materials and methods and activity was measured by incorporation of 32 P into an S6 peptide. Activity is expressed relative to basal kinase activity without exposure to IR. The pro®les are an average of three independent experiments, error bars represent the standard error of the mean (s.e.m.). (c) Phospho-blot analysis of p70 S6K phosphorylation sites. Samples were harvested 15 min following 2 Gy. Forty mg of protein was separated by 4 ± 8% PAGE, transferred to nitrocellulose, and blotted with phospho-speci®c antibodies to p70 S6K (anti-T421/ S424, anti-T389). The blots were then stripped and reprobed with an antibody to p70 S6K (anti-S6 Kinase) to insure equal loading. The observed bands are 70 and 85 Kd representing the two isoforms of p70 S6K signi®cantly change the basal activity of p70 S6K (Figure 1b) .
To complement the kinase activity data, phosphoblot analyses of p70 S6K were performed in A431 cells in order to monitor the involvement of speci®c phosphorylation sites following IR exposure. The results demonstrate an increase in phosphorylation of both the T421/S424 and T389 sites. Both phosphorylation sites are proposed to be involved in regulating the activity of p70 S6K (Weng et al., 1998) and, in agreement with the kinase activity data (Figure 1a,b) , these sites are inhibited by LY294002 and AG1478 treatments (Figure 1c) .
In summary, this data demonstrates that both basal and IR-stimulated P70 S6K activities are regulated by a LY294002 sensitive enzyme, that is likely PI3K. Additionally, the results indicate that stimulation of p70 S6K in response to IR is dependent on EGFR function for both A431 and MDA-MB231 cells, but also suggest that p70 S6K activation in MDA-MB231 cells is regulated by another signal transduction pathway.
Activation of Akt and p70 S6K by IR in MDA-MB-231 cells is dependent on Erb-B2
We have previously reported that IR activates Akt in MDA-MB-231 cells . Akt is transiently activated 2.0+0.1-fold, within minutes following exposure to 2 Gy (Figure 2a) . However, no activation of Akt by IR is seen in A431 cells (data not shown), suggesting fundamental dierences with regard to Akt regulation in these two cell lines. Because we have shown that EGFR inhibition alters IR-induced MAPK and p70S6K activities, we next investigated the eects of EGFR inhibition on Akt activity. Our results demonstrate that treatment of MDA-MB-231 cells with AG1478 does not signi®- Kinase assays were performed as described in Materials and methods and show the time course of Akt activity following exposure to 2 Gy. Activity is measured by incorporation of 32 P into a GSK-3 peptide. The activation pro®le is an average of three independent experiments, error bars represent the s.e.m. (b) Eect of kinase inhibitors on IR-induced Akt activity. MDA-MB-231 cells were pretreated for 1 h with either AG1478 or AG825 or for 1.5 h with LY294002. Kinase activity with each drug treatment was measured at 15 min. Results are the average of three independent experiments and are expressed as the fold activation compared to non-irradiated control samples. Signi®cant activation of Akt was seen for control (P50.01), AG1478 (P50.01), and LY294002 (P50.01), although LY294002 also signi®cantly decreased basal Akt activation (P50.01). (c) Western blot analysis of Akt phosphorylation sites using phospho-speci®c antibodies (Anti-S473 and Anti-T308). The samples were harvested 15 min following exposure to 2 Gy. The protein was separated using 4 ± 10% PAGE to resolve the Akt band from a prominent, non-speci®c band present in MDA-MB-231 cells that reacts strongly with the anti-T308 antibody. To insure the identity of the Akt band, an FGF stimulated NIH3T3 cell lysate was included as a positive control (PC) and the blot was then stripped and reprobed with an anti-Akt antibody. (d) p70 S6K activity in MDA-MB-231 cells following pharmacologic inhibition with AG1478, AG825, or both AG1478 and AG825. Activity was measured 10 min following IR and the results are the average of three independent experiments cantly alter basal or IR-induced Akt activity ( Figure  2b ). Similarly, inhibition of Src family kinases with PP1 did not block IR-induced activation of Akt (data not shown). Treatment of MDA-MB-231 cells with LY294002 reduces basal Akt activity to approximately 60% of control samples, but again signi®cant activation of Akt by IR is observed under these conditions. This data suggests that IR-induced activation of Akt is independent of EGFR function and partially independent of PI3K activity.
Because IR is a pleiotropic activator of all Erb-B receptors (Bowers et al., 2001) , we investigated whether IR activates Akt by an Erb-B2 dependent mechanism. Pretreatment of MDA-MB-231 cells with the Erb-B2 speci®c tyrphostin, AG825 (Levitzki and Gazit, 1995) , completely blocks IR-induced activation of Akt ( Figure  2b ). Phospho-blot analysis of IR stimulated Akt samples were also performed to complement the kinase activity data. IR stimulates phosphorylation of both the S473 and T308 sites of Akt, however, only the phosphorylation of T308 is blocked by pretreatment with AG825 ( Figure 2c ). These results suggest that while IR increases phosphorylation of both of these regulatory sites, Erb-B2 functions as an upstream regulator of T308.
MDA-MB-231 cells also dier from A431 cells in that AG1478 does not completely block all IR-induced p70 S6K activity. We therefore compared the eects of EGFR or Erb-B2 inhibition on IR stimulated p70 S6K activity. Neither inhibitor signi®cantly reduces basal levels of p70 S6K activity but both inhibit IR-induced activation by approximately 50%. In combination, AG1478 and AG825 lower basal p70 S6K activity and reduce IR stimulated levels to the same as nonirradiated control samples ( Figure 2d ). Taken together this data demonstrates that p70 S6K activity is regulated by both EGFR and Erb-B2 dependent signal transduction pathways in the MDA-MB-231 breast carcinoma cell line.
MAPK contributes to the activation of p70 S6K
Prior investigations have identi®ed p42/44 MAPK as downstream signaling intermediates activated by IR in an EGFR dependent manner (Schmidt-Ullrich et al., 1997; Dent et al., 1999) . Recently, phosphorylation of p70 S6K by p42/44 MAPK has been shown to regulate kinase activity in vitro (reviewed in Weng et al., 1998) . To determine the role of MAPK, we examined the eects of the MEK1 speci®c inhibitor, PD 98059, on IR-induced activation of p70 S6K in A431 cells. Inhibiting MEK1 has no eect on basal p70 S6K activity but almost completely blocks the increase in activity caused by IR (Figure 3a) . Western blot analysis of proposed MAPK phosphorylation sites on p70 S6K, illustrates that phosphorylation of p70 S6K in response to IR is completely blocked by MEK1 inhibition (Figure 3b ). Treatment with rapamycin, an Figure 3 Eects of MEK inhibition on IR induced p70 S6K activity in A431 cells. (a) Kinase activation of p70 S6K in response to 2 Gy as compared to samples pretreated with 10 mM PD98059 or 20 nM Rapamycin. Activity was measured 15 min following exposure to IR or 10 min following 10 ng/ml EGF treatment (E). Results are the average of three independent experiments, error bars represent the s.e.m. PD98059 did not alter the basal activity of p70 S6K, but did signi®cantly block its activation by IR (P50.01). (b) Phospho-blot analysis depicting the 70 and 85 Kd isoforms of p70 S6K. Representative Western blots show the change in phosphorylation levels of p70 S6K following IR or treatment with 10 mM PD or 20 nM Rap. Forty mg of total cellular protein was separated by 4 ± 8% PAGE. The protein was transferred to nitrocellulose and blotted with an antibody that speci®cally recognizes phosphorylation sites of the p70 S6K (anti-T421/S424, anti-T389). In order to insure equal loading, the blot was stripped and reprobed with an antibody that recognizes p70 S6K (anti-S6 Kinase) mTOR inhibitor, blocks p70 S6K activity and phosphorylation as well, suggesting that mTOR also regulates p70 S6K activity in these carcinoma cells (Figure 3b ).
IR increases association and activity of PI3K with Erb-B3 p70 S6K activity is completely blocked by treatment with LY294002 (Figure 1 ). Because this compound can also inhibit mTOR, we directly investigated the eects of IR on PI3K. The EGFR does not contain a consensus sequence for protein ± protein interactions with the regulatory subunit of PI3K (p85), however, the third member of the Erb-B family expressed by these cells (Bowers et al., 2001; Lammering et al., 2001b) , Erb-B3, contains two of these motifs. We therefore examined the association of p85 with Erb-B3 in co-immunoprecipitation experiments. Two Gy increases the association of p85 with Erb-B3 2.6+0.6-fold in A431 cells (Figure 4a ) and 1.6-fold in MDA cells (data not shown). This association is accompanied by a 2.8+0.6-fold increase in tyrosine phosphorylation of the Erb-B3 receptor in A431 cells and a 1.8-fold increase in MDA-MB-231 cells (data not shown). Because Erb-B3 does not contain a functional kinase domain, its tyrosine phosphorylation is dependent upon interactions such as heterodimerizations with other Erb-B receptors (Solto et al., 1994) . We show that pretreating with the EGFR inhibitor, AG1478, blocks both tyrosine phosphorylation of Erb-B3 as well as its association with p85 in A431 cells (Figure 4a) .
Immunoprecipitation of Erb-B3 has previously been used to quantify the catalytic activity of receptor associated PI3K in response to growth factor (Solto et al., 1994) . By taking this approach, we have demonstrated that IR activates Erb-B3 associated PI3K activity 2.0+0.1-fold (Figure 4c ). This ®nding is in agreement with the increased association of p85 and is also blocked by AG1478 treatment. In combination, these results indicate that IR induces EGFR dependent Erb-B3 phosphorylation that triggers signaling through the PI3K pathway.
IR activates p90 S6K in an EGFR and MAPK dependent fashion
Previous studies have shown that p90 S6K is activated by IR (Kharbanda et al., 1994; Carter et al., 1998) . The time course of activation is similar to that of p70 S6K with a peak of activation within 10 min followed by a return to basal conditions over 45 min (Figure 5a ). Like p70 S6K, basal and IR stimulated p90 S6K activities are blocked by AG1478 showing that these two kinases require EGFR signaling for activity in these carcinoma cell lines. However, p90 S6K is more sensitive to treatment with PD98059 than p70 S6K. Both basal and radiation stimulated p90 S6K activities are reduced to 47+3% of controls (Figure 5b ). In contrast, PD98059 has no eect on basal p70 S6K activity (Figure 3a) . These results are in agreement with current signaling models that implicate MAPK as an activator of p90 S6K activity (Sturgill et al., 1988) and a co-activator of p70 S6K (Weng et al., 1998; Dennis et al., 1998) . Control experiments were also performed to insure the relative speci®cities of the antibodies used for these experiments (Figure 5c ).
Radiation increases the translation of 5' oligopyrimidinerich mRNAs
The established role of p70 S6K in protein translation prompted us to examine the interaction of IR and EGFR function on p70 S6K dependent translation. p70 S6K modulates the translation of mRNAs containing a 5' tract of oligopyrimidines (5'TOP) (Jeeries et al., 1994; Schwab et al., 1999) . mRNAs containing this sequence include ribosomal proteins, elongation factors (Terada et al., 1994) and a poly-A binding protein (Hornstein et al., 1999) . For these experiments, A431 Tyrosine phosphorylation and co-precipitation of p85/PI3K with Erb-B3 following exposure to 2 Gy. A431 cells were treated with or without 5 mM AG1478 1 h prior to experimentation. Immunoprecipitation was performed as described in Materials and methods. The protein was then separated by 4 ± 6% PAGE. After transferring to nitrocellulose, the membrane was cut in half. The top was blotted for anti-phosphotyrosine and the bottom was blotted for the regulatory subunit of PI3K, p85. A parallel gel with equal aliquots of protein was run and probed for Erb-B3 to insure equal amounts of protein in each sample. (b) Increased Erb-B3 associated PI3K catalytic activity following exposure to 2 Gy. Erb-B3 was immuno-precipitated as in (a) and activity was measured by 32 P incorporation into phosphatidyl-inositol. AG1478 treatment is the same as above. The results are representative of three independent experiments cells were used because they demonstrated larger IRinduced p70 S6K activation (Figure 1a) , inhibition with AG1478 decreased p70 S6K activity by almost an order of magnitude as compared to untreated samples (Figure 3) , and AG1478 also inhibited p90 S6K activity (Figure 5b ). IR activates translation of the 5'TOP vector for up to 45 min following exposure to 2 Gy whereas it does not increase translation of the control luciferase reporter vector lacking the 5'TOP sequence (Figure 6a) . A dose of 2 Gy increases translation of the 5'TOP(+) vector 1.8+0.2-fold and pretreatment with AG1478 blocks the IR-induced translation of this 5'TOP vector by approximately 75% (Figure 6b ). These results demonstrate that exposure of A431 cells to low doses of radiation causes increased translation of 5'TOP mRNAs by a mechanism that is dependent on EGFR function.
AG825 enhances apoptosis in MDA-MB-231 cells
We also investigated the eects of EGFR and Erb-B2 inhibition on apoptosis in MDA-MB-231 cells. Four Gy was used in these experiments because 2 Gy had only a small eect on apoptosis. Twenty-four hours following IR, apoptosis increased from 1.3 to 2.6%. Pretreatment with AG1478 did not signi®cantly enhance apoptosis in MDA-MB-231 cells. However, AG825, which blocked IR-induced Akt activation, combined with radiation to signi®cantly increase the number of apoptotic cells to 4.4% alone and to 5.3% when the cells were pretreated with AG825 and AG1478. These results demonstrate that inhibition of Erb-B2 kinase activity enhances IR-induced apoptosis, and suggest that this enhancement occurs in part through the inhibition of Akt (Figure 7 ). p90 S6K was immunoprecipitated and activity was measured by incorporation of 32 P into the S6 peptide. Activation is expressed as fold increase relative to control samples not exposed to IR. (b) Eects of MEK and EGFR inhibition on p90 S6K activity. Ten mM PD98059 or 5 mM AG1478 treatments were for 1 h prior to irradiation. Cells were harvested 15 min after irradiation. The results are the average of three independent experiments and show signi®cant inhibition of basal and stimulated p90 S6K activity by AG1478 (P50.01) and PD98059 (P50.01). Again, the results are expressed in fold activation as compared to non-irradiated controls and error bars represent the s.e.m. (c) Speci®city of antibodies used for immunoprecipitation. Immunoprecipitates obtained with either anti-p70 S6K or anti-p90 S6K were run in parallel lanes on a 4 ± 8% gel, transferred, and then probed with either the p70 or p90 antibody
Discussion
In this study we have characterized the role of Erb-B receptors in the activation of p70 S6K and Akt by IR. Our results demonstrate that IR activates multiple Erb-B dependent signal transduction pathways that coordinately regulate p70 S6K activity. Previous work demonstrated that IR activates all Erb-B receptors Bowers et al., 2001 ), and our current ®ndings indicate that each receptor can contribute to p70 S6K activity, resulting in the regulation of cellular biosynthesis. We have also investigated the stimulation of Akt by IR in MDA-MB-231 cells. Akt activity has been implicated as a key pathway in opposing apoptosis (Kennedy et al., 1999) , and our data demonstrate that Erb-B2 inhibition both blocks IR-stimulated Akt activity and enhances IRinduced apoptosis in this cell line. Finally we have demonstrated, for the ®rst time, that a clinically relevant dose of IR modulates the activity of ribosomes to preferentially translate 5'TOP mRNAs, a class of RNAs encoding proteins that enhance the translational capability of the cell (Schwab et al., 1999; Hornstein et al., 1999) . Together these results delineate a model for the signaling mechanisms that underlie the cytoprotective response to IR (Figure 8 ).
In this investigation we have used small molecule inhibitors to study the relative roles of Erb-B receptors in mediating cytoprotective signals in carcinoma cells. The tyrphostin Erb-B inhibitors used for this mechanistic study provided two advantages over the genetic, dominant negative (DN) approach to Erb-B receptor inhibition. First, DN Erb-B deletion mutants such as the EGFR-CD533 have inhibitory eects on multiple Erb-B receptors (Spivak-Kroizman et al., 1992; JN Contessa and RK Schmidt-Ullrich unpublished observations), whereas small molecule inhibitors have been demonstrated to have a high degree of speci®city (Levitzki and Gazit, 1995; Bowers et al., 2001) . Second, disrupting Erb-B RTKs using a DN approach exposes the cells to increasing levels of the trans-gene over a period of 48 h. This is in contrast to small molecule inhibitors, which can be used to disrupt Erb-B signaling immediately prior to IR exposure. The pharmacologic approach to Erb-B receptor inhibition was, therefore, more suited for both identifying and dissecting the Erb-B dependent responses to IR.
The use of two carcinoma cell lines helped to elucidate both the hierarchy and complexity by which IR activates p70 S6K. In A431 cells, activation of p70 S6K is dependent on EGFR function by at least two mechanisms. First, through interactions with the kinase de®cient Erb-B3 receptor, EGFR kinase activity regulates the recruitment and stimulation of PI3K, an event that sequentially precedes p70 S6K activation. Second, EGFR activation by IR initiates a similar transient increase in MAPK activity (Schmidt-Ullrich et al., 1997; Contessa et al., 1999) which also precedes and is necessary for the activation of p70 S6 Kinase. This data is in agreement with current models of p70 S6K regulation, which identify phosphorylation by MAPK as a step in relieving auto-inhibitory constraints and phosphorylation by PI3K/PDK-1 in regulating the active site of p70 S6K (Dennis et al., 1998; Vanhaesebroeck and Alessi, 2000) . In MDA-MB-231 cells, further work demonstrated IR-induced p70 S6K activity that is refractory to either speci®c EGFR or Erb-B2 inhibition, sensitive to combined EGFR and Erb-B2 inhibition, and coincident with Erb-B2 dependent Akt activation. This data identi®es Erb-B2 as another upstream RTK whose activity contributes to the coordinate regulation of p70 S6K by IR.
Unlike MAPK or p70 S6K, the activation of Akt in MDA-MB-231 cells is independent of EGFR function, and although the PI3K inhibitor, LY294002, decreases basal activity levels of this enzyme, signi®cant activation of Akt is still produced in the presence of this inhibitor. Importantly, Akt activation is present even though LY294002 abolishes almost all p70 S6K activity. This is evidence that IR-induced activation of Akt is partially independent of PI3K. Examples of PI3K independent activation of Akt have been described previously. Expression of upstream oncogenes such as Src and Ras produce Akt activity that is not completely abolished by PI3K inhibitors (Liu et al., 1998) and others have demonstrated that the calmodulin kinase kinase (Yano et al., 1998 ) is a PI3K independent mechanism for Akt activation. The cellular stresses of heat shock, hyperosmolarity (Konishi et al., 1996) , and H 2 O 2 treatment have also been identi®ed as stimuli that can cause Akt activation.
Herein we have demonstrated a link between Erb-B2 function and Akt activity. Although pharmacologic inhibition of two TKs, the EGFR and Src, do not reduce IR-induced Akt activation, inhibition of Erb-B2 is sucient to block the IR-induced stimulation of kinase activity as well as the phosphorylation of T308, a key regulatory site for Akt. However, Erb-B2 activation only partially accounts for the observed Akt stimulation because A431 cells express Erb-B2 but do not demonstrate IR-induced activation of Akt. To date, four S/T (Alessi et al., 1996) and two Y (Chen et al., 2001) phosphorylation sites have been identi®ed in Akt. The number of sites underscores the inherent complexity of regulating Akt activity, which like p70 S6K, is likely to occur at multiple levels. Although we have identi®ed Erb-B2 as a key mediator of this response, additional experiments are required to completely de®ne the mechanisms of Akt activation following exposure to IR.
IR-induced, EGFR dependent activation of MAPK is a cytoprotective response to radiation for carcinoma cells (Schmidt-Ullrich et al., 1997) . Signaling through both p70 S6K and Akt also represent fundamental mechanisms by which IR activated Erb-B receptors can generate protective signals. The data presented demonstrate that inhibition of Erb-B RTKs both prevents IRstimulated translation of mRNAs that comprise several components of the cellular biosynthetic machinery as well as enhances IR-induced apoptosis. In conclusion, this work provides further evidence of how Erb-B receptor activation contributes to the evasion of radiation-induced cell death and implicates the activation of p70 S6K and Akt by low doses of IR as cytoprotective responses.
In this study we have used speci®c pharmacologic inhibitors of the EGFR and Erb-B2 RTKs to dissect the pathways for IR-induced PI3K/p70 S6K and Akt signaling. The results demonstrate that IR-induced Erb-B receptors generate multiple cytoprotective signals dependent on the Erb-B receptor complement expressed by the cell. Previously, we have demonstrated that a genetic approach to EGFR inhibition radiosensitizes carcinomas cells Lammering et al., 2001b) . Other investigators, using either pharmacologic approaches (Rao et al., 2000; Akimoto et al., 2001) or a monoclonal antibody to the EGFR (Huang et al., 1999; Milas et al., 2000) have also shown EGFR inhibition as a means of radiosensitizing carcinoma cells. However, in this study we demonstrate that for MDA-MB-231 cells, the combined use of EGFR and Erb-B2 inhibitors may be advantageous because it further decreased IR-induced Akt and p70 S6K signaling. These ®ndings therefore imply that in some carcinoma cell types, a strategy that targets multiple Erb-B receptors may provide broader 
Materials and methods
Reagents
All Reagents were purchased from Sigma Chemical Company (St. Louis, MO, USA) unless otherwise speci®ed. Antibodies to the EGFR (No.5) and phosphotyrosine (No.2) as well as protein G plus and protein A/G plus agarose beads were purchased from Calbiochem (La Jolla, CA, USA). Immunoprecipitation antibodies for p70 S6K (sc-230), p90 S6K (sc-231), and Akt (sc-1619) as well as the GSK-3 and S6 peptide substrates were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The phospho-antibodies to p70 S6K and Akt and the positive control lysate for Akt were from Cell Signaling (Beverly, MA, USA). Antibodies recognizing Erb-B3 and p85/PI3K were from Neomarkers (Fremont, CA, USA) and Upstate Biotechnology (Lake Placid, NY, USA), respectively. The kinase inhibitors, AG1478, AG825, LY294002, PD98059, PP1, and Rapamycin were also purchased from Calbiochem. Radiochemicals were from ICN (Costa Mesa, CA, USA) and Potassium Oxalate TLC plates were purchased from Analtech (Newark, DE, USA).
Cell culture and irradiation
MDA-MB-231 mammary carcinoma cells and A431 squamous carcinoma cells were purchased from ATCC. Cell treatments for these cell lines have been described previously . Brie¯y, the cell lines were maintained in RPMI supplemented with 5% FCS. Prior to irradiation, the cells were placed in low serum medium (RPMI plus 0.5% FCS) for 16 h. The ®nal cell culture density prior to irradiation was approximately 90%. Pretreatment with inhibitors was for either 1 h with 5 mM AG1478, 5 mM AG825, 10 mM PD98059, or 20 nM Rapamycin or for 1.5 h with 1 mM PP1 or 50 mM LY294002.
For all experiments except for the apoptosis assay, the cells were exposed to a dose of 2 Gy from a 60 Co source at a dose rate of 1.8 Gy per min. Time points were then taken following the end of the irradiation. The culture dishes were washed once in ice-cold PBS, frozen on dry ice, and stored at 7808C for further experimentation.
Measurement of apoptosis
Apoptosis rates were determined 24 h following exposure to 4 Gy. The culture medium and trypsinized cells were centrifuged and resuspended in methanol: acetic acid (3 : 1). The cells were then washed twice more in methanol : acetic acid, pipetted onto microscope slides and allowed to air dry. Following Giemsa staining, an average of 1500 cells were counted per slide to determine the per cent of apoptosis.
Transfection with luciferase reporters
For transfection experiments, A431 cells were seeded at a density of 1610 5 in 3 cm dishes. The following day, transfections were performed using the lipofectamine transfection kit (Life Technologies, Gaithersburg MD, USA) according to the manufacturer's protocol. A431 cells were transfected with 2 mg of either the 5'TOP(+) or 5'TOP (7) vectors (a kind gift from Dr James Maller) which have been described previously (Schwab et al., 1999) . The 5'TOP vector contains a 5' terminal oligopyrimidine sequence from the hamster EF2 gene linked to the luciferase reporter gene in the PGL2 vector. Twenty-four hours following transfection, the culture medium was changed to RPMI plus 0.5% FCS. The following day the plates were irradiated, washed in PBS, and frozen as above.
The Promega (Madison, WI, USA) Luciferase Assay System was used to measure luciferase production. Samples were lysed in 16 cell lysis buer and centrifuged at 14 000 r.p.m. The pellet was discarded and a 100 ml aliquot of lysate was measured for luciferase activity in a Lumat LB9501 luminometer.
Immunochemical analysis
Lysis and immunoprecipitation of cells, except for PI3K assays, was performed according to methods standard in our laboratory . For each experiment, equal amounts of protein were used for immunoprecipitation or Western blot analysis. One milligram of protein was used for A431 immunoprecipitations and 600 ± 700 mg of protein was used for MDA-MB-231 immunoprecipitations. Samples were incubated with the appropriate antibody with constant rotation at 48C for 2 h. Protein A/G or protein G plus beads were then added for an additional 1.5 h. After centrifugation of the immune complex, the samples were washed once in lysis buer, once in a 0.1% Triton lysis buer, and then twice in PBS for Western blots or once in a reaction buer containing 20 mM BGP, 15 mM MgCl 2 for kinase assays. Western blot analysis and kinase reactions were performed as described previously .
For PI3K assays, the methods of Solto et al. (1994) were used with modi®cations. The Neomarkers anti-Erb-B3 antibody and ProteinA/G plus agarose were used for immunoprecipitation. After pelleting, the precipitate was washed twice in PBS and twice in 0.5 M LiCl, 0.1 M Tris pH 7.4, 1 mM EDTA, both containing 200 mM Na ortho-vanadate. After the ®nal aspiration, 10 mg of sonicated phosphatidylinositol in 40 ml of 10 mM HEPES, 1 mM EGTA was added to each sample on ice. The kinase reaction was started at room temperature by the addition of a 56 kinase buer containing 10 mM Tris pH 7.4, 75 mM MgCl 2 , 500 mM ATP, and 32 P (10 mCi per reaction). Reactions were allowed to proceed for 10 min and then stopped by the addition of 80 ml of 1 M HCl. The lipids were then extracted with 160 ml of methanol-chloroform (1 : 1), and dried in a chemical hood after removing the aqueous phase. The lipids were resuspended in 50 ml of methanol : chloroform (2 : 1) and a 10 ml aliquot of the sample was spotted onto Whatmann paper and subjected to scintillation counting. Equal counts of each sample were then loaded onto glass, potassium oxalate TLC plates and developed overnight in chloroform, methanol, ammonium hydroxide (9 : 7 : 2).
